SIA
JNJ icon

Soltis Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Soltis Investment Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.8M Sell
48,328
-10,362
-18% -$2.41M 0.75% 19
2025
Q4 		$12.1M Buy
58,690
+2,540
+5% +$502K 0.8% 17
2025
Q3 		$10.4M Buy
56,150
+1,923
+4% +$329K 0.72% 23
2025
Q2 		$8.28M Sell
54,227
-137
-0.3% -$21.1K 0.65% 30
2025
Q1 		$9.02M Buy
54,364
+18,384
+51% +$2.88M 0.81% 22
2024
Q4 		$5.2M Sell
35,980
-1,597
-4% -$247K 0.48% 59
2024
Q3 		$6.09M Buy
37,577
+1,357
+4% +$216K 0.6% 47
2024
Q2 		$5.29M Buy
36,220
+613
+2% +$91.2K 0.56% 56
2024
Q1 		$5.63M Buy
35,607
+689
+2% +$110K 0.63% 51
2023
Q4 		$5.47M Sell
34,918
-1,119
-3% -$172K 0.62% 48
2023
Q3 		$5.61M Sell
36,037
-1,965
-5% -$324K 0.72% 41
2023
Q2 		$6.29M Buy
38,002
+2,963
+8% +$478K 0.73% 28
2023
Q1 		$5.43M Buy
35,039
+3,761
+12% +$607K 0.69% 32
2022
Q4 		$5.53M Buy
31,278
+3,406
+12% +$588K 0.73% 28
2022
Q3 		$4.55M Buy
27,872
+3,855
+16% +$652K 0.69% 32
2022
Q2 		$4.26M Buy
24,017
+4,140
+21% +$738K 0.62% 35
2022
Q1 		$3.52M Buy
19,877
+1,915
+11% +$326K 0.49% 44
2021
Q4 		$3.07M Buy
17,962
+987
+6% +$162K 0.43% 46
2021
Q3 		$2.74M Buy
16,975
+531
+3% +$90.6K 0.42% 47
2021
Q2 		$2.71M Buy
16,444
+1,051
+7% +$174K 0.43% 44
2021
Q1 		$2.53M Buy
15,393
+1,255
+9% +$203K 0.46% 40
2020
Q4 		$2.23M Buy
14,138
+1,770
+14% +$261K 0.41% 40
2020
Q3 		$1.84M Buy
12,368
+917
+8% +$136K 0.43% 46
2020
Q2 		$1.61M Buy
11,451
+1,471
+15% +$214K 0.42% 44
2020
Q1 		$1.31M Buy
9,980
+2,668
+36% +$379K 0.41% 42
2019
Q4 		$1.07M Buy
+7,312
New +$992K 0.21% 56

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Soltis Investment Advisors's JNJ Position: Q1 2026 in Review

Soltis Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 18% in Q1 2026, selling an estimated $2.41M and leaving 48,328 shares worth $11.8M. The position accounts for 0.75% of the portfolio, ranked #19.

Soltis Investment Advisors first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. The position peaked at $12.1M in Q4 2025. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Soltis Investment Advisors held 48,328 shares of Johnson & Johnson worth $11.8M as of Q1 2026.
  • Soltis Investment Advisors sold 10,362 Johnson & Johnson shares in Q1 2026, an estimated $2.41M.
  • Johnson & Johnson made up 0.75% of Soltis Investment Advisors's portfolio in Q1 2026, its #19 holding.
  • Soltis Investment Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
  • Soltis Investment Advisors's Johnson & Johnson position peaked at $12.1M in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Soltis Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.